Home  |  Contact

UniProtKB/Swiss-Prot P12277: Variant p.Ser309Leu

Creatine kinase B-type
Gene: CKB
Variant information

Variant position:  309
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  Polymorphism
The variants are classified into three categories: Disease, Polymorphism and Unclassified.
  • Disease: Variants implicated in disease according to literature reports.
  • Polymorphism: Variants not reported to be implicated in disease.
  • Unclassified: Variants with uncertain implication in disease according to literature reports. Evidence against or in favor of a pathogenic role is limited and/or conflicting.

Residue change:  From Serine (S) to Leucine (L) at position 309 (S309L, p.Ser309Leu).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from small size and polar (S) to medium size and hydrophobic (L)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -2
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  309
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  381
The length of the canonical sequence.

Location on the sequence:   TGLRAGVHIKLPNLGKHEKF  S EVLKRLRLQKRGTGGVDTAA
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         TGLRAGVHIKLPNLGKHEKFSEVLKRLRLQKRGTGGVDTAA

                              TGLRAGVHIKLPHLGKHEKFPEVLKRLRLQKRGTGGVDTAA

Mouse                         TGLRAGVHIKLPHLGKHEKFSEVLKRLRLQKRGTGGVDTAA

Rat                           TGLRAGVHIKLPHLGKHEKFSEVLKRLRLQKRGTGGVDTAA

Pig                           TGLRAGVHIKLPHLGKHEKFPEVLKRLRLQKRGTGGVDTAA

Bovine                        TGLRAGVHIKLPHLGKHEKFPEVLKRLRLQKRGTGGVDTAA

Rabbit                        TGLRAGVHIKLPHLGQHEKFSEVLKRLRLQKRGTGGVDTAA

Chicken                       TGLRAGVHIKLPNLGKHEKFGEVLKRLRLQKRGTGGVDTAA

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 2 – 381 Creatine kinase B-type
Domain 125 – 367 Phosphagen kinase C-terminal
Binding site 292 – 292 ATP
Binding site 320 – 320 ATP
Modified residue 309 – 309 Phosphoserine
Modified residue 322 – 322 Phosphothreonine
Mutagenesis 292 – 292 R -> HLQ. Complete loss of activity.
Mutagenesis 292 – 292 R -> K. 42% of wild-type activity.
Helix 308 – 314


Literature citations

Submission
NIEHS SNPs program;
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS ARG-177 AND LEU-309;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.